Get started
Author

Cynthia Levy

Observed names: C Levy, C. Levy
Institution: University of Miami
ORCID: 0000-0001-5498-6037
Observed ORCID: 0000-0001-5498-6037
OpenAlex ID: A5061567306
Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group
2022 · Simon Pape, Romée J.A.L.M. Snijders, et al. · Journal of Hepatology · 183
PDF
Impact of Alkaline Phosphatase Normalization on Complication-Free Survival in Primary Biliary Cholangitis
2026 · Anish Reddy, Adrielly Martins, et al. · The American Journal of Gastroenterology · 5
Comorbidity Burden and Biologic Access in an Uninsured Psoriasis Population: A 20‐Year Descriptive Study
2026 · Simonetta I. Gaumond, Sammya Mufarrej, et al. · International Journal of Dermatology · 4
PDF
Seladelpar Improves Cholestasis and Pruritus in Obeticholic Acid and Fibrate-Experienced Patients With Primary Biliary Cholangitis
2026 · Stuart C. Gordon, Sarah Proehl, et al. · Clinical Gastroenterology and Hepatology · 2
Outcome of COVID-19 in Patients with Autoimmune Hepatitis: an International Multi-Centre Study
2021 · Cumali Efe, Renumathy Dhanasekaran, et al. · Author eBooks · 2
Long-term efficacy and safety of elafibranor in primary biliary cholangitis: Interim results from the open-label extension of the ELATIVE trial up to 3 years
2025 · K V Kowdley, C L Bowlus, et al. · Zeitschrift für Gastroenterologie · 1
Linerixibat significantly improves cholestatic pruritus in primary biliary cholangitis: results of the pivotal Phase 3 GLISTEN trial
2025 · G M Hirschfield, C L Bowlus, et al. · Zeitschrift für Gastroenterologie
Works count: 7
Citation count: 197
H-index: 3
I10-index: 1
Year
Topic
Type